HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High-Mobility Group Nucleosome-Binding Protein 1 as Endogenous Ligand Induces Innate Immune Tolerance in a TLR4-Sirtuin-1 Dependent Manner in Human Blood Peripheral Mononuclear Cells.

Abstract
High-mobility group nucleosome-binding protein 1 (HMGN1) functions as a non-histone chromatin-binding protein in the cell nucleus. However, extracellular HMGN1 acts as an endogenous danger-associated inflammatory mediator (also called alarmin). We demonstrated that HMGN1 not only directly stimulated cytokine production but also had the capacity to induce immune tolerance by a TLR4-dependent pathway, similar to lipopolysaccharide (LPS)-induced tolerance. HMGN1-induced tolerance was accompanied by a metabolic shift associated with the inhibition of the induction of Warburg effect (aerobic glycolysis) and histone deacetylation via Sirtuin-1. In addition, HMGN1 pre-challenge of mice also downregulated TNF production similar to LPS-induced tolerance in vivo. In conclusion, HMGN1 is an endogenous TLR4 ligand that can induce both acute stimulation of cytokine production and long-term tolerance, and thus it might play a modulatory role in sterile inflammatory processes such as those induced by infection, trauma, or ischemia.
AuthorsRob J W Arts, Po-Kai Huang, De Yang, Leo A B Joosten, Jos W M van der Meer, Joost J Oppenheim, Mihai G Netea, Shih-Chin Cheng
JournalFrontiers in immunology (Front Immunol) Vol. 9 Pg. 526 ( 2018) ISSN: 1664-3224 [Print] Switzerland
PMID29593748 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • HMGN1 Protein
  • Ligands
  • Toll-Like Receptor 4
  • Sirtuin 1
Topics
  • Animals
  • Cytokines (blood)
  • Female
  • HMGN1 Protein (immunology)
  • Humans
  • Immune Tolerance
  • Immunity, Innate
  • Leukocytes, Mononuclear (immunology)
  • Ligands
  • Mice, Inbred C57BL
  • Sirtuin 1 (immunology)
  • Toll-Like Receptor 4 (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: